Search - tctmd.com

Displaying 1 - 20 of 96

Sort: Relevancy | Date

News Daily News

Frail Patients Stand to Gain Most From Cardiac Rehab

Michael O'Riordan

November 26, 2025

News Opinion Editor's Corner TCT 2025

What’s Going to Be Hot at TCT 2025

Michael O'Riordan

October 09, 2025

News Daily News

Infective Endocarditis Risk Much Higher a Decade After MV Replacement vs Repair

Todd Neale

July 31, 2025

News Conference News NY Valves 2025

Solid, Early Surgical Results With Polymer Mitral Valve

Todd Neale

July 02, 2025

News Conference News STS 2025

Surgery Outdoes Percutaneous Treatment for Patients With CAD, Aortic Stenosis

Yael L. Maxwell

February 05, 2025

News Conference News STS 2025

Surgeons: Be Active in Tricuspid Procedures or Be ‘Left Behind’

Yael L. Maxwell

February 05, 2025

News Conference News STS 2025

Amid Declining Use, Mechanical SAVR Valves Beat Bioprosthetic for Survival

Yael L. Maxwell

January 27, 2025

News Daily News

Top Structural Heart News of 2024

L.A. McKeown

December 29, 2024

Presentation AHA 2024

Efficacy and safety of EdoxabaN in anticoagulant therapy after surgical Bioprosthetic vALVe replacement

Presenter: Chisato Izumi

November 17, 2024

News Conference News AHA 2024

GLORIOUS: Neither Exenatide Nor Restrictive Oxygenation Boost CV Surgery Outcomes

Michael O'Riordan

November 17, 2024

News Conference News AHA 2024

ENBALV: Edoxaban Matches Warfarin After Bioprosthetic Valve Surgery

Yael L. Maxwell

November 17, 2024

News Conference News NY Valves 2024

National Data Point to Soaring TAVI Rates in Patients Under 65

Michael O'Riordan

June 14, 2024

News Conference News NY Valves 2024

Polymer Mitral Valve Shows Well Early, but Long-term Data Key

Michael O'Riordan

June 12, 2024

News Conference News NY Valves 2024

Good 3-Year Outcomes With Aortic Valve-in-Valve Replacement for Failed SAVR

Michael O'Riordan

June 11, 2024

News Conference News EuroPCR 2024

TAVI, Surgery Look Similar Long-term Across Risk Spectrum: Meta-analysis

Michael O'Riordan

May 16, 2024

News Conference News EuroPCR 2024

Young, Low-risk Patients Fare Well With TAVI, but Beware the Bicuspids

Michael O'Riordan

May 15, 2024

Presentation EuroPCR 2024

Long-term outcomes of transcatheter aortic valve vs. surgical aortic valve replacement

Presenter: Eliano Navarese

May 15, 2024

News Conference News

TAVI Use Rising in Young US Patients, Yet Another Analysis Shows

Yael L. Maxwell

May 06, 2024

News Daily News

STS Releases New Risk-Prediction Tools for Emerging Surgical Scenarios

Yael L. Maxwell

May 01, 2024

Another Win for TAVI in Low-to-Intermediate Risk Patients

News Conference News ACC 2024

Another Win for TAVI in Patients at Low-to-Intermediate Risk: DEDICATE-DZHK6

Yael L. Maxwell

April 08, 2024

Advertisement

Frail Patients Stand to Gain Most From Cardiac Rehab

What’s Going to Be Hot at TCT 2025

Infective Endocarditis Risk Much Higher a Decade After MV Replacement vs Repair

Solid, Early Surgical Results With Polymer Mitral Valve

Surgery Outdoes Percutaneous Treatment for Patients With CAD, Aortic Stenosis

Surgeons: Be Active in Tricuspid Procedures or Be ‘Left Behind’

Amid Declining Use, Mechanical SAVR Valves Beat Bioprosthetic for Survival

Top Structural Heart News of 2024

Efficacy and safety of EdoxabaN in anticoagulant therapy after surgical Bioprosthetic vALVe replacement

GLORIOUS: Neither Exenatide Nor Restrictive Oxygenation Boost CV Surgery Outcomes

ENBALV: Edoxaban Matches Warfarin After Bioprosthetic Valve Surgery

National Data Point to Soaring TAVI Rates in Patients Under 65

Polymer Mitral Valve Shows Well Early, but Long-term Data Key

Good 3-Year Outcomes With Aortic Valve-in-Valve Replacement for Failed SAVR

TAVI, Surgery Look Similar Long-term Across Risk Spectrum: Meta-analysis

Young, Low-risk Patients Fare Well With TAVI, but Beware the Bicuspids

Long-term outcomes of transcatheter aortic valve vs. surgical aortic valve replacement

TAVI Use Rising in Young US Patients, Yet Another Analysis Shows

STS Releases New Risk-Prediction Tools for Emerging Surgical Scenarios

Another Win for TAVI in Patients at Low-to-Intermediate Risk: DEDICATE-DZHK6

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content